Parathyroid Hormone Receptors: Potential Drug Targets for Bone Disease

Target Name: Parathyroid Hormone Receptors (PTHR)

NCBI ID: P14486

Parathyroid Hormone Receptors (PTHR)

Other Name(s): None

Parathyroid Hormone Receptors: Potential Drug Targets for Bone Disease

Parathyroid Hormone Receptors (PTHR) are a family of G protein-coupled receptors (GPCRs) that are expressed in the parathyroid gland, a small gland located in the neck that produces calcium and vitamin D. PTHRs play a crucial role in regulating calcium and vitamin D levels in the body, and are often targeted by drugs for the treatment of various diseases.

PTHRs are classified into two subtypes, PTHR1 and PTHR2. PTHR1 is the most abundant subtype, and is responsible for the majority of PTHR-mediated signaling in the parathyroid gland. PTHR2 is a less abundant subtype that is involved in PTHR signaling in the brain.

PTHRs are involved in a wide range of physiological processes in the body, including calcium homeostasis, bone development and maintenance, and neurotransmission. They are also involved in the regulation of several diseases, including bone disease, osteoporosis, and diabetes.

Due to their involvement in a wide range of physiological processes, PTHRs have become a focus for drug development for the treatment of various diseases. One of the most promising areas of research is the use of PTHRs as drug targets for the treatment of bone disease, including osteoporosis and bone fractures.

PTHRs have also been shown to be involved in the regulation of neurotransmission, and are thought to play a role in the development and maintenance of neurotransmitter systems. This has led to the use of PTHRs as potential biomarkers for the diagnosis and treatment of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to their potential use as drug targets and biomarkers, PTHRs are also of interest in the study of pharmacology and physiology. The PTHR gene is known to be involved in the regulation of parathyroid gland function, and variations in PTHR gene expression have been observed in various diseases, including osteoporosis and diabetes.

Overall, PTHRs are a promising area of research, with a wide range of potential applications in the treatment of various diseases. Further studies are needed to fully understand the role of PTHRs in physiological processes and their potential as drug targets and biomarkers.

Protein Name: Parathyroid Hormone Receptors (PTHR) (nonspecified Subtype)

The "Parathyroid Hormone Receptors (PTHR) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Parathyroid Hormone Receptors (PTHR) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets